Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
human placental mesenchymal stem cell gel
- Development stage
- Unknown
- Lead developer
- Beijing Health-Biotech Stem Cell Technology
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Topical
01
Overview
Human placental mesenchymal stem cell gel is an innovative cell therapy developed by Beijing Health-Biotech Stem Cell Technology (Han's Stem Cell) specifically for the treatment of diabetic foot ulcers (DFU). The product consists of mesenchymal stem cells (MSCs) isolated from human placental tissue, which are then formulated into a gel for topical application directly onto chronic wounds. These placental MSCs are characterized by their high proliferative capacity, low immunogenicity, and potent paracrine activity. Once applied to the ulcer, the cells secrete a variety of bioactive factors, including vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), and various anti-inflammatory cytokines. This secretome promotes angiogenesis, accelerates re-epithelialization, and modulates the chronic inflammatory environment typical of diabetic wounds, thereby facilitating the healing of otherwise recalcitrant ulcers.
- Other names
- Human Placental Mesenchymal Stem Cell Gel人胎盘间充质干细胞凝胶
Beyond the preview
Go deeper on human placental mesenchymal stem cell gel.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on human placental mesenchymal stem cell gel.